Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
DIVISLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Divi's Laboratories has submitted its financial results for the quarter and half-year ended September 30, 2025 to the stock exchange. The filing is a procedural intimation confirming that the results have been filed, but the detailed figures on revenue, profit, margins, and segment performance are not included in this particular notice. Investors would need to refer to the actual results document or press release for the specific numbers. Divi's is one of India's largest active pharmaceutical ingredients (API) manufacturers, so these results will indicate the company's earnings trajectory in the current fiscal year.
This is a routine regulatory filing and does not by itself move the stock. The actual numbers in the results document will be the key driver of investor reaction and any near-term price movement.